Neurizon’s fast-track application for flagship drug in Europe received ‘positively’
While the final decision is set for next month, biotech player Neurizon’s…
Wed, 13 Nov | Close | Change |
4:53pm | 8,193.4 | 62.2 |
Closed at Thu, 14 Nov 6:28am |
S&P/ASX Sm. Ords. | 3,118.6 | 38.7 | 1.23% |
All Ordinaries | 8,450.9 | 64.3 | 0.76% |
S&P/ASX 100 | 6,887.6 | 50.1 | 0.72% |
SWF | SELFWEALTH LIMITED | 20.5¢ | 70.8% |
DUB | DUBBER CORPORATION LIMITED | 2.8¢ | 47.4% |
OLL | OPENLEARNING LIMITED | 2.8¢ | 47.4% |
OCT | OCTAVA MINERALS LIMITED | 10.0¢ | 23.1% |
NXL | NUIX LIMITED | $5.90 | 22.2% |
OVT | OVANTI LIMITED | 3.2¢ | 22.0% |